Lung

The FDA issued a complete response letter to Spectrum Pharmaceuticals indicating it could not approve the company’s new drug application that sought approval of poziotinib as treatment for certain patients with lung cancer.

While the 2021 consensus guidelines for pulmonary disease in Sjögren’s syndrome may have shed light on this underdiagnosed complication, gaps remain in identification and management of the disease, noted a presenter here.

Higher circulating levels of the protein CTRP9 are associated with worse lung function in patients with systemic sclerosis-related interstitial lung disease, according to data published in Arthritis Care & Research.